Regeneron Pharmaceuticals, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2008 | 99.6% | -36.2% | -33.2% |
| FY2009 | 99.6% | -19.5% | -17.9% |
| FY2010 | 99.5% | -21.2% | -22.8% |
| FY2011 | 99.1% | -46.0% | -49.7% |
| FY2012 | 93.9% | 33.2% | 54.4% |
| FY2013 | 94.4% | 35.3% | 19.7% |
| FY2014 | 95.4% | 29.2% | 12.0% |
| FY2015 | 94.1% | 30.5% | 15.5% |
| FY2016 | 96.0% | 27.4% | 18.4% |
| FY2017 | 96.6% | 35.4% | 20.4% |
| FY2018 | 95.4% | 49.3% | 47.5% |
| FY2019 | 93.9% | 33.7% | 32.3% |
| FY2020 | — | 42.1% | 41.3% |
| FY2021 | — | 55.7% | 50.2% |
| FY2022 | — | 38.9% | 35.6% |
| FY2023 | — | 30.9% | 30.1% |
| FY2024 | — | 28.1% | 31.1% |
| FY2025 | — | 24.9% | 31.4% |